2022 Annual Scientific Meeting

Thursday 1st of December

Please select the agenda for your meeting using the menu below

 

 

Contents

  1. PSGB&I ASM
  2. National HPB Nurse Group meeting

PSGB&I ASM

 

Thursday 01st December 2022

Parallel Subspecialty Sessions
PSGBI 
 
08.50 - 09.00  Welcome 
   
09.00 - 09.15  Opening Address
09.15 - 19.30  How  does a large NHS Trust enhance a small expensive  regional  service?  
   
  Pancreatic Cancer Services 
09.30 - 09.45  What actually happens to our pancreatic cancer patients - RICHOCET and CONTACT studies 
09.45 - 10.00 Developing pathways to improve  pancreatic cancer management 
10.00 - 10.15  What do our patients want from a pancreatic cancer serivce? 
10.15 - 10.30  Setting up and maintaining a local pancreatic cancer support service - PANPALS
   
10.30 to 11:00  
   
11:00 to 12.30  Current approaches in pancreatic cancer 
   
11.00 - 11.15  At risk groups to screen for pancreatic cancer 
11.15 - 11.30  Precision Oncoclogy in Pancreatic Cancer 
11.30 - 11.45  What is the current evidence for neoadjuvant therapy in PDAC ?
11.45 - 12.00 Immunotherapy in PDAC 
12.00 - 12.15  Should we perform either Arterial and venous resections after neoadjuvant therapy ?
12.15 - 12.30  Can we effectively assess surgical  performance at Whipples ?
   
12.30 to 13.30  LUNCH 
12.30 to 13:30  
13.30 to 14.20   LORD SMITH MEDAL ORAL PRESENTATIONS 
 

1. Improving risk stratification of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas, the results of the two-centre transatlantic study.

2. A retrospective cohort study investigating the progression of sarcopenia and its impact on outcomes in patients with pancreatic cancer undergoing neoadjuvant chemotherapy

3. Current Practice and Opinion Regarding Postoperative Feeding Regimens in Pancreatoduodenectomy Patients: Basis for a National Trial?

4. Evaluating aspirin & metformin in relation to a prognostic role. Analysis of ESPAC 4 randomised trial of adjuvant gemcitabine versus gemcitabine plus capectabine in resected pancreatic cancer patients

5. Sarcopenic obesity is common in patients admitted to critical care with severe acute pancreatitis and is a strong predictor of mortality.  
   
14.20 - 15.10 Local Control of Pancreatic Cancer 
14.20 - 14.32  LAP-PIE trial 
14.32 - 14.44 Margin accentuation  using irreversible electroporation   
14.44 - 14.56  EUS-guided ablation therapy
14.56 - 15.10   Intra- operative Radiotherapy in PDAC  
   
15.10 - 15.40   
15.40 - 17.30 Update on acute pancreatitis  
15:30 - 15:40 A patients perspective on severe acute pancreatitis 
15:40 - 15.55  Relation of early severity and necrotizing pancreatitis, critical illness trajectories in acute pancreatitis 
15.55 - 16.10 PANC study update 
16.10 - 16.25   Pancreatitis priority setting partnership 
16.25 - 16.40 Optimal timing of interventions in necrotizing pancreatitis (Pointer study) 
16.40 - 16.55 Oral feeding intolerance. Introduction of enteral nutrition, appropriate timing and method
16.55 - 17.10  Optimising pain control in acute pancreatitis  
17.00 - 17.15  Psychosocial impact of nectrotizing pancreatitis 

 

19:00 Pre dinner drinks followed by Gala dinner @19:30
 

Register for the meeting here

 

  

Back to top

National HPB Nurse Group meeting

National HPB Nurse Group meeting 1st December

The NHpbNG will join the other delegates for the 1st session in the morning

08.50 – 09.00 Welcome

09.00 – 09.15 How does the pancreatic community effectively lobby?

09.15 – 09.30 How does a large NHS Trust enhance a small expensive regional service?

09.30 – 09.45 What actually happens to Pancreatic Cancer patients – RICHOCET and CONTACT Studies

09.45 – 10.00 Developing pathways to improve pancreatic cancer management

10.00 – 10.15 What do our patients want from a pancreatic cancer service?

10.15-10.30 Setting up and maintaining a local pancreatic cancer support service - PANPALS

10.30 – 11.00 Coffee Break

11.00 – 11.05 Welcome to the morning session – Phil

11.05 – 1130 – National Hpb Nurse Group update; Lynne McCallum Pancreatic Cancer Nurse Specialist PCUK

1130 – 1230 CNS Roles during COVID: Impact and Moving Forward Dr Anna Taylor Leeds and York Partnership NHS Foundation Trust

12.30 – 13.30 Lunch

13.30 – 13.35 Welcome to the afternoon session – Claire P

13.35 – 13.55 Tissue is the Issue; Professor Juan Valle Consultant Oncologist Manchester

13.55 – 14.15 Our Pancreatic Unit during COVID 19; Phil Whelan Macmillan Pancreatic CNS Liverpool University Foundation Hospital Trust  

14.15 – 14.30 Development of a national Best Practice Timed Pathway (BPTP) for HPB cancers; Peter De Rosa, Policy and Health Improvement Manager, Pancreatic Cancer UK London

14.30 – 14.50 Pancreas RDS, the challenges and successes; Vicki Stevenson-Hornby Specialist Nurse for the Pancreas and HPB Rapid Diagnostic Service Blackburn

14.50- 15.10 The CNS role in Personalised Care; Carolynne Hardy UGi/HPB CNS and Personalised Cancer Care Manager South Tyneside & Sunderland NHS Foundation Trust

1510 – 1525 – Comfort break

15.25 - 15.45 “A Pancreatic Tale” a story of survival; Barb Ashall Lead Upper Gastrointestinal Cancer Nurse Specialist St Helens & Knowsley Hospitals

15.45- 16.05 Radiotherapy, SABR and Proton Beam; update for practice; Dr Ganesh Radhakrishna Consultant Clinical Oncologist Manchester

16.05- 16.25 Monitoring the HPB patient experience; Claire Pearce, Lead Macmillan HPB CN Clinical Nurse University Hospital Coventry and Warwickshire

1625-1645 Supportive care research: Pancreatic Cancer UK's vision & ambitions Chris Macdonald, Head of Research PCUK & Charlotte Lynch, Research Strategy Manager PCUK

1645-1700 Closing of meeting and travel reimbursement Lynne 

Back to top